SVB Wealth LLC Has $16.50 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

SVB Wealth LLC lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 12.4% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 31,347 shares of the healthcare conglomerate’s stock after selling 4,435 shares during the period. SVB Wealth LLC’s holdings in UnitedHealth Group were worth $16,503,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Kraft Davis & Associates LLC lifted its position in shares of UnitedHealth Group by 3.4% in the 3rd quarter. Kraft Davis & Associates LLC now owns 577 shares of the healthcare conglomerate’s stock worth $294,000 after acquiring an additional 19 shares during the period. Iron Horse Wealth Management LLC lifted its position in shares of UnitedHealth Group by 1.6% in the 3rd quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate’s stock worth $614,000 after acquiring an additional 19 shares during the period. Secure Asset Management LLC lifted its position in shares of UnitedHealth Group by 0.8% in the 3rd quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate’s stock worth $1,238,000 after acquiring an additional 19 shares during the period. Bensler LLC lifted its position in shares of UnitedHealth Group by 0.3% in the 3rd quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock worth $3,677,000 after acquiring an additional 19 shares during the period. Finally, Texas Capital Bancshares Inc TX lifted its position in shares of UnitedHealth Group by 1.1% during the 3rd quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock worth $855,000 after buying an additional 19 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling

In related news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by corporate insiders.

UnitedHealth Group Stock Up 5.4 %

Shares of UnitedHealth Group stock traded up $23.86 during trading on Tuesday, reaching $469.49. The stock had a trading volume of 5,987,957 shares, compared to its average volume of 4,314,540. The company has a market capitalization of $432.84 billion, a price-to-earnings ratio of 19.62, a P/E/G ratio of 1.20 and a beta of 0.54. The stock has a fifty day moving average price of $491.15 and a two-hundred day moving average price of $515.88. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.54 by $0.37. The company had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The company’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same period in the previous year, the company posted $6.26 earnings per share. Sell-side analysts predict that UnitedHealth Group Incorporated will post 27.7 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.60%. UnitedHealth Group’s payout ratio is presently 31.54%.

Analyst Ratings Changes

Several equities analysts recently commented on the company. Royal Bank of Canada restated an “outperform” rating and set a $596.00 target price on shares of UnitedHealth Group in a research report on Thursday, February 29th. Morgan Stanley lowered their target price on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research note on Friday, April 5th. Wells Fargo & Company lowered their target price on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. HSBC raised UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price for the company in a research note on Thursday, April 4th. Finally, Bank of America reissued a “buy” rating and issued a $675.00 target price on shares of UnitedHealth Group in a research note on Thursday, March 7th. Three research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus target price of $573.80.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.